Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …

The explosion of the new coronavirus (SARS-CoV-2) pandemic has brought the role of the
angiotensin converting enzyme 2 (ACE2) back into the scientific limelight. Since SARS-CoV …

Abstract Background & Aims Coronavirus disease 2019 (COVID‐19) has raised world
concern for global epidemic since December, 2019. Limited data are available for liver …

Background Liver function derangements have been reported in coronavirus disease
(COVID-19), but reported rates are variable. Methods We searched PubMed and Embase …

Introduction and objectives The coronavirus disease 2019 (COVID-19) pandemic has been
a challenge globally. In severe acute respiratory syndrome (SARS) epidemic 60% of …

In the past few years, the classical concept of the renin–angiotensin system (RAS) has
experienced substantial conceptual changes. The identification of: the renin/prorenin …

Background Angotensin converting enzyme 2 (ACE2) is a newly discovered
monocarboxypeptidase that counteracts the vasoconstrictor effects of angiotensin II (Ang II) …

The liver is a crucial metabolic organ that has a key role in maintaining immune and
endocrine homeostasis. Accumulating evidence suggests that chronic liver disease might …

It is well known that the RAS (renin–angiotensin system) plays a key role in the modulation
of many functions in the body. AngII (angiotensin II) acting on AT1R (type 1 AngII receptor) …

The coronaviruses that cause notable diseases, namely, severe acute respiratory syndrome
(SARS), middle east respiratory syndrome (MERS) and coronavirus disease 2019 (COVID …